Acadia Pharma (ACAD) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $25.20 -0.47%
Revenue Growth %: +11.8%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +11.8%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Canaccord
- Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)
- AeroVironment (AVAV) Tops Q4 EPS by 36c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
